Table 2 Plasma levels of markers of inflammation (hsCRP), microbial translocation (LPS, sCD14, and LBP) and gastrointestinal damage (I-FABP) in ME/CFS and healthy individuals

From: Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome

Analytes	Control	ME/CFS
hsCRP (mg/L)
n	34	46
Median	1.21	1.38
Quartiles	0.38–2.69	0.70–2.71
Range	0.27–5.09	0.23–19.3
LPS (pg/mL)
n	39	49
Median	74.74	119.43
Quartiles	54.34–99.54	66.21–144.41
Range	32.21–187.32	34.32–279.30
I-FABP (pg/mL)
n	33	44
Median	234.40	255.85
Quartiles	159.75–412.90	171.275–450.70
Range	14–1067.9	23.2–909.9
sCD14 (ug/mL)
n	39	49
Median	1.36	1.97
Quartiles	1.09–1.67	1.71–2.32
Range	0.62–2.42	0.95–3.02
LBP (ug/mL)
n	37	49
Median	12.32	17.68
Quartiles	10.22–13.73	13.04–22.56
Range	8.65–18.76	7.06–34.52

Back to article page